Anson Funds Management LP 13D and 13G filings for NRx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:53 pm Purchase | 2025-06-30 | 13G | NRx Pharmaceuticals, Inc. NRXP | Anson Funds Management LP | 1,604,975 9.300% | 425,914 (+36.12%) | Filing |
| 2025-05-15 5:15 pm Purchase | 2025-03-31 | 13G | NRx Pharmaceuticals, Inc. NRXP | Anson Funds Management LP | 1,179,061 7.000% | 1,179,061 (New Position) | Filing |